Medicare Enrolled
Dr. Christopher Stockdale
Urology Physician · Redding, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Stockdale from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Stockdale?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Stockdale
Dr. Christopher Stockdale is an urology physician in Redding, CA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Stockdale performed 7,999 Medicare services across 3,097 unique beneficiaries.
Between the years covered by Open Payments, Dr. Stockdale received a total of $412 from 12 pharmaceutical and/or device companies across 18 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Stockdale is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 13% volume in CA
$412 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,999
Medicare services
Top 13% in CA for urology physician
3,097
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~727 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,101 | $2 | $5 |
| Leuprolide injectable, camcevi, 1 mg | 1,638 | $65 | $119 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
865 | $3 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
555 | $95 | $225 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
485 | $64 | $150 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
371 | $8 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
334 | $123 | $340 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
312 | $0 | $2 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
223 | $189 | $475 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 126 | $132 | $500 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
89 | $82 | $220 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
77 | $47 | $170 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
75 | $26 | $90 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
65 | $4 | $10 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
63 | $184 | $515 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
63 | $49 | $275 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
56 | $19 | $47 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
56 | $117 | $225 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
52 | $41 | $95 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
50 | $62 | $200 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
49 | $72 | $255 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
39 | $26 | $40 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
38 | $137 | $300 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
33 | $20 | $45 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
31 | $104 | $1,016 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
29 | $256 | $570 |
| Simple change of bladder tube | 24 | $82 | $215 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
24 | $303 | $1,097 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
23 | $64 | $226 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
15 | $2,369 | $7,795 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
15 | $59 | $320 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $106 | $308 |
| Cystourethroscopy with ureteroscopy or pyeloscopy A diagnostic procedure using an endoscope to examine the bladder, urethra, and ureter or kidney. |
11 | $224 | $828 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
12.8% medium
86.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$412
Total received (2021-2024)
Avg $103/year across 4 years
Bottom 23% in CA for urology physician
12
Companies
18
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$412 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$98
2023
$182
2022
$115
2021
$17
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Laborie Medical Technologies Corp.
$42
Axonics, Inc.
$21
Endo USA, Inc.
$19
ABBVIE INC.
$16
Top 3 companies account for 83.4% of 2024 payments
All-time payments by company (2021-2024) ›
Astellas Pharma US Inc
$83
Agiliti Surgical, Inc.
$55
Axonics, Inc.
$45
Boston Scientific Corporation
$44
Laborie Medical Technologies Corp.
$42
AbbVie Inc.
$34
ACCORD HEALTHCARE, INC.
$25
Endo USA, Inc.
$19
Endo Pharmaceuticals Inc.
$17
Olympus America Inc.
$17
ABBVIE INC.
$16
Coloplast Corp
$15
Top 3 companies account for 44.6% of all-time payments
Associated products mentioned in payments ›
AVEED · Axonics · CAMCEVI · CYSTO-NEPHRO VIDEOSCOPE · LUPRON DEPOT · Optilume BPH Drug Coated Balloon Catheter · Porges Coloplast · Rezum Generator · Soltive TFL PREMIUM LASER SYSTEM · SpaceOAR VUE System - 10mL · XIAFLEX · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
6
Per 100K population
3.3
County median income
$71,931
Nearest hospital
MERCY MEDICAL CENTER REDDING
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Stockdale is a clinical cardiology specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Stockdale experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Stockdale performed 2,101 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Stockdale receive payments from pharmaceutical companies?
Yes. Dr. Stockdale received a total of $412 from 12 companies across 18 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Stockdale's costs compare to other urology physicians in Redding?
Dr. Stockdale's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Stockdale) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Redding
Browse urology physicians in Redding ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Agiliti Surgical, Inc. Payments to Doctors
See all physicians who received payments from Agiliti Surgical, Inc.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology